Tschopp J M, Sistek D, Schindler C, Leuenberger P, Perruchoud A P, Wüthrich B, Brutsche M, Zellweger J P, Karrer W, Brändli O
Centre Valaisan de Pneumologie, Montana.
Allergy. 1998 Jun;53(6):608-13. doi: 10.1111/j.1398-9995.1998.tb03937.x.
Total serum IgE, Phadiatop, and the skin prick test (SPT) are commonly used to diagnose atopic diseases. However, no large study has ever been done to test their diagnostic efficiency. We studied the diagnostic value of these three atopic markers in 8329 well-randomized adults from the Swiss Population Registry. The prevalence of current allergic asthma (CAA) was 1.8% and of current allergic rhinitis (CAR) 16.3%. The prevalences of positive Phadiatop, positive SPT (at least, one out of eight SPT to common aeroallergens with a wheal of > or = 3 mm), and positive total IgE (IgE > or = 100 kU/l) were 29, 23, and 23%, respectively. To diagnose CAA and CAR, the sensitivity of Phadiatop was significantly higher than that of SPT (72.5% vs 65.4%, 77.1% vs 68.4% respectively; P < 0.01 and < 0.001) and IgE (72.5% vs 56.9%, 77.1% vs 43.9%, respectively; both P < 0.001). The sensitivity of SPT was significantly higher (68.4% vs 43.9% P < 0.001) than that of IgE to diagnose CAR. When CAA and CAR were excluded, the SPT specificity was significantly higher than that of Phadiatop (77.8% vs 71.9% and 85.9% vs 80.5%, respectively; both P < 0.001): when CAR was excluded, SPT was significantly higher than IgE (85.9 vs 81.4%; P < 0.001). SPT had significantly the best positive predictive value for CAA (5.2% for SPT vs 4.6% for both IgE and Phadiatop; both P < 0.001) and CAR (48.7% for SPT vs 43.5% for Phadiatop and 31.6% for IgE; both P < 0.001). The three markers of atopy had roughly the same negative predictive value (NPV) for CAA, but IgE had a significantly lower NPV for CAR than SPT and Phadiatop (88.1% vs 93.3% and 94.7%, respectively; both P < 0.001). The diagnostic efficiency of SPT was significantly higher than that of Phadiatop (83.1% vs 79.9% and 77.6 vs 71.9%, respectively; both P < 0.001) to diagnose CAR and CAA. IgE and SPT had equal efficiency (77.6%), which was significantly higher than that of Phadiatop, to diagnose CAA (71.9%; both P < 0.001). In conclusion, SPT have the best positive predictive value and the best efficiency to diagnose respiratory atopic diseases. Furthermore, SPT give information on sensitivity to individual allergens and should therefore be used primarily by clinicians to assess respiratory allergic diseases. Moreover, they are cheaper and provide immediate, educational information for both patient and physician.
血清总免疫球蛋白E、变应原筛查组合试验(Phadiatop)以及皮肤点刺试验(SPT)常用于诊断特应性疾病。然而,此前尚未有大规模研究对它们的诊断效能进行检验。我们对瑞士人口登记处8329名随机抽取的健康成年人进行研究,以评估这三种特应性标志物的诊断价值。当前过敏性哮喘(CAA)的患病率为1.8%,当前过敏性鼻炎(CAR)的患病率为16.3%。Phadiatop阳性、SPT阳性(对常见气传变应原进行8次皮肤点刺试验中至少有1次风团直径≥3毫米)以及血清总免疫球蛋白E阳性(免疫球蛋白E≥100 kU/l)的患病率分别为29%、23%和23%。对于CAA和CAR的诊断,Phadiatop的敏感性显著高于SPT(分别为72.5%对65.4%,77.1%对68.4%;P<0.01和<0.001)以及免疫球蛋白E(分别为72.5%对56.9%,77.l%对43.9%;P均<0.001)。对于CAR的诊断,SPT的敏感性显著高于免疫球蛋白E(68.4%对43.9%,P<0.001)。排除CAA和CAR后,SPT的特异性显著高于Phadiatop(分别为77.8%对71.9%以及85.9%对80.5%;P均<0.001):排除CAR后,SPT的特异性显著高于免疫球蛋白E(85.9%对81.4%;P<0.001)。对于CAA,SPT的阳性预测值显著最佳(SPT为5.2%,免疫球蛋白E和Phadiatop均为4.6%;P均<0.001),对于CAR也是如此(SPT为48.7%,Phadiatop为43.5%,免疫球蛋白E为31.6%;P均<0.001)。这三种特应性标志物对CAA的阴性预测值大致相同,但对于CAR,免疫球蛋白E的阴性预测值显著低于SPT和Phadiatop(分别为88.1%对93.3%和94.7%;P均<0.001)。在诊断CAR和CAA方面,SPT的诊断效能显著高于Phadiatop(分别为83.1%对79.9%以及77.6%对71.9%;P均<0.001)。免疫球蛋白E和SPT的诊断效能相同(77.6%),在诊断CAA方面显著高于Phadiatop(71.9%;P均<0.001)。总之,SPT在诊断呼吸道特应性疾病方面具有最佳的阳性预测值和最佳效能。此外,SPT能提供对个体变应原的敏感性信息,因此临床医生应主要使用SPT来评估呼吸道过敏性疾病。而且,它们成本更低,能为患者和医生提供即时的、有指导意义的信息。